Microbot Medical Inc
MBOT3.190USD
+0.100+3.24%
Cierre 09/19, 16:00（ET）Cotizaciones retrasadas 15 min
121.09MCap. mercado
PérdidaP/E TTM
Más Datos de Microbot Medical Inc Compañía
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
Información de la empresa
Símbolo de cotizaciónMBOT
Nombre de la empresaMicrobot Medical Inc
Fecha de salida a bolsaMar 25, 1992
Director ejecutivoMr. Harel Gadot
Número de empleados21
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 25
Dirección175 Derby St Bld 27
CiudadHINGHAM
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02043
Teléfono17818753605
Sitio Webhttp://www.microbotmedical.com/
Símbolo de cotizaciónMBOT
Fecha de salida a bolsaMar 25, 1992
Director ejecutivoMr. Harel Gadot
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Scott R. Burell
Mr. Scott R. Burell
Independent Director
Independent Director
--
--
Ms. Aileen Ptucha Stockburger, CPA
Ms. Aileen Ptucha Stockburger, CPA
Independent Director
Independent Director
--
--
Mr. Simon Sharon
Mr. Simon Sharon
Chief Technology Officer, General Manager of Microbot Israel
Chief Technology Officer, General Manager of Microbot Israel
--
--
Mr. Martin J. Madden
Mr. Martin J. Madden
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Tal Wenderow
Mr. Tal Wenderow
Independent Director
Independent Director
--
--
Mr. David J. Wilson
Mr. David J. Wilson
Independent Director
Independent Director
--
--
Mr. Prattipati Laxminarain
Mr. Prattipati Laxminarain
Independent Director
Independent Director
--
--
Dr. Juan Diaz-Cartelle
Dr. Juan Diaz-Cartelle
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Rachel Vaknin
Ms. Rachel Vaknin
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Harel Gadot
Mr. Harel Gadot
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: jue., 11 de sep
Actualizado: jue., 11 de sep
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
3.88%
CIBC Private Wealth Management
1.16%
Geode Capital Management, L.L.C.
0.75%
BlackRock Institutional Trust Company, N.A.
0.59%
DNB Asset Management AS
0.37%
Otro
93.25%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
3.88%
CIBC Private Wealth Management
1.16%
Geode Capital Management, L.L.C.
0.75%
BlackRock Institutional Trust Company, N.A.
0.59%
DNB Asset Management AS
0.37%
Otro
93.25%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
5.01%
Investment Advisor/Hedge Fund
2.96%
Research Firm
0.47%
Venture Capital
0.29%
Hedge Fund
0.13%
Bank and Trust
0.03%
Corporation
0.01%
Otro
91.10%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
93
3.71M
8.26%
-749.31K
2025Q1
89
2.58M
7.86%
-1.62M
2024Q4
78
1.58M
4.97%
-880.54K
2024Q3
70
1.52M
8.93%
-946.72K
2024Q2
71
1.56M
9.80%
-833.62K
2024Q1
69
2.54M
18.61%
-153.32K
2023Q4
67
2.61M
22.30%
+489.30K
2023Q3
65
2.09M
17.88%
-264.50K
2023Q2
64
2.33M
23.62%
-218.94K
2023Q1
63
2.51M
30.86%
-204.69K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
741.16K
2.04%
+281.62K
+61.28%
Mar 31, 2025
Geode Capital Management, L.L.C.
316.92K
0.87%
+174.26K
+122.15%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
236.10K
0.65%
+98.73K
+71.87%
Mar 31, 2025
DNB Asset Management AS
114.82K
0.32%
--
--
Mar 31, 2025
State Street Global Advisors (US)
136.67K
0.38%
+110.60K
+424.24%
Mar 31, 2025
MEDX Ventures Group LLC
136.85K
0.38%
--
--
Apr 15, 2025
Northern Trust Investments, Inc.
71.06K
0.2%
+57.67K
+430.78%
Mar 31, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
